PBA
Paradigm Biocapital Advisors’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.3M | Buy |
10,352,449
+1,388,794
| +15% | +$9.97M | 3.17% | 9 |
|
|
2025
Q1 | $53.7M | Buy |
8,963,655
+4,046,243
| +82% | +$24.2M | 2.46% | 12 |
|
|
2024
Q4 | $38.4M | Buy |
4,917,412
+307,650
| +7% | +$2.4M | 1.33% | 19 |
|
|
2024
Q3 | $49.8M | Buy |
4,609,762
+985,420
| +27% | +$10.6M | 1.68% | 17 |
|
|
2024
Q2 | $30.6M | Buy |
+3,624,342
| New | +$30.6M | 1.17% | 24 |
|
|
2023
Q4 | – | Sell |
-225,605
| Closed | -$2.2M | – | 30 |
|
|
2023
Q3 | $2.2M | Buy |
+225,605
| New | +$2.2M | 0.15% | 29 |
|